Suppr
超能文献

Targeting angiogenesis from premalignancy to metastases.

作者信息

Grandis Jennifer R, Argiris Athanassios

机构信息

Department of Otolaryngology, University of Pittsburgh School of Medicine and Cancer Institute, Pittsburgh, PA, USA.

出版信息

Cancer Prev Res (Phila). 2009 Apr;2(4):291-4. doi: 10.1158/1940-6207.CAPR-09-0032. Epub 2009 Mar 31.

DOI:10.1158/1940-6207.CAPR-09-0032

PMID:19336719

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10031626/

Abstract

摘要

相似文献

Targeting angiogenesis from premalignancy to metastases.

Cancer Prev Res (Phila). 2009 Apr;2(4):291-4. doi: 10.1158/1940-6207.CAPR-09-0032. Epub 2009 Mar 31.

Tumor angiogenesis: molecular pathology, therapeutic targeting, and imaging.

Acad Radiol. 2000 Oct;7(10):800-11. doi: 10.1016/s1076-6332(00)80629-7.

Less is more.

EMBO Rep. 2003 Sep;4(9):831-4. doi: 10.1038/sj.embor.embor934.

Angiogenesis: a "common denominator" of disease?

J Am Pharm Assoc (Wash). 2000 Jul-Aug;40(4):564-5.

Combating angiogenesis early: potential of targeting tumor-recruited neutrophils in cancer therapy.

Future Oncol. 2012 Jan;8(1):5-8. doi: 10.2217/fon.11.133.

[Research advancement of endogenous angiogenesis inhibitors].

Ai Zheng. 2005 Mar;24(3):376-84.

Targeting angiogenic metabolism in disease.

Science. 2018 Mar 23;359(6382):1335-1336. doi: 10.1126/science.aar5557.

[Systemic and cellular pathways of anti-tumor action of plant adaptogenes].

Vopr Onkol. 2009;55(1):15-23.

Anti-angiogenesis immunotherapy.

Hum Vaccin. 2011 Sep;7(9):976-81. doi: 10.4161/hv.7.9.16407. Epub 2011 Sep 1.

[Progress of study on effect of Chinese materia medica on angiogenesis].

Zhongguo Zhong Xi Yi Jie He Za Zhi. 2002 Mar;22(3):221-3.

引用本文的文献

Use of multikinase inhibitors/lenvatinib in patients with synchronous/metachronous cancers coinciding with radioactive-resistant differentiated thyroid cancer.

Cancer Med. 2022 Oct;11 Suppl 1(Suppl 1):26-32. doi: 10.1002/cam4.5107.

Construction of a disulfide-stabilized diabody against fibroblast growth factor-2 and the inhibition activity in targeting breast cancer.

Cancer Sci. 2016 Aug;107(8):1141-50. doi: 10.1111/cas.12981. Epub 2016 Jul 26.

Aberrant NRP-1 expression serves as predicator of metastatic endometrial and lung cancers.

Oncotarget. 2016 Feb 16;7(7):7970-8. doi: 10.18632/oncotarget.6699.

Convergence of nanotechnology and cancer prevention: are we there yet?

Cancer Prev Res (Phila). 2014 Oct;7(10):973-92. doi: 10.1158/1940-6207.CAPR-14-0079. Epub 2014 Jul 24.

Antiangiogenic therapy: impact on invasion, disease progression, and metastasis.

Nat Rev Clin Oncol. 2011 Mar 1;8(4):210-21. doi: 10.1038/nrclinonc.2011.21.

Tumor and host-mediated pathways of resistance and disease progression in response to antiangiogenic therapy.

Clin Cancer Res. 2009 Aug 15;15(16):5020-5. doi: 10.1158/1078-0432.CCR-09-0095. Epub 2009 Aug 11.

本文引用的文献

Sunitinib prolongs survival in genetically engineered mouse models of multistep lung carcinogenesis.

Cancer Prev Res (Phila). 2009 Apr;2(4):330-7. doi: 10.1158/1940-6207.CAPR-08-0213. Epub 2009 Mar 31.

ABT-510 is an effective chemopreventive agent in the mouse 4-nitroquinoline 1-oxide model of oral carcinogenesis.

Cancer Prev Res (Phila). 2009 Apr;2(4):385-93. doi: 10.1158/1940-6207.CAPR-08-0211. Epub 2009 Mar 31.

LKB1/KRAS mutant lung cancers constitute a genetic subset of NSCLC with increased sensitivity to MAPK and mTOR signalling inhibition.

Br J Cancer. 2009 Jan 27;100(2):370-5. doi: 10.1038/sj.bjc.6604886.

Targeting RET for thyroid cancer therapy.

Biochem Pharmacol. 2009 Feb 1;77(3):297-309. doi: 10.1016/j.bcp.2008.10.033. Epub 2008 Nov 6.

Primary and secondary kinase genotypes correlate with the biological and clinical activity of sunitinib in imatinib-resistant gastrointestinal stromal tumor.

J Clin Oncol. 2008 Nov 20;26(33):5352-9. doi: 10.1200/JCO.2007.15.7461. Epub 2008 Oct 27.

Role of LKB1 in lung cancer development.

Br J Cancer. 2008 Sep 2;99(5):683-8. doi: 10.1038/sj.bjc.6604515. Epub 2008 Aug 19.

von Hippel-Lindau gene status and response to vascular endothelial growth factor targeted therapy for metastatic clear cell renal cell carcinoma.

J Urol. 2008 Sep;180(3):860-5; discussion 865-6. doi: 10.1016/j.juro.2008.05.015. Epub 2008 Jul 17.

Mutations in the LKB1 tumour suppressor are frequently detected in tumours from Caucasian but not Asian lung cancer patients.

Br J Cancer. 2008 Jul 22;99(2):245-52. doi: 10.1038/sj.bjc.6604469. Epub 2008 Jul 1.

Multicenter, phase II trial of sunitinib in previously treated, advanced non-small-cell lung cancer.

J Clin Oncol. 2008 Feb 1;26(4):650-6. doi: 10.1200/JCO.2007.13.9303.

LKB1 modulates lung cancer differentiation and metastasis.

Nature. 2007 Aug 16;448(7155):807-10. doi: 10.1038/nature06030. Epub 2007 Aug 5.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Suppr超能文献

Targeting angiogenesis from premalignancy to metastases.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译